Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with ...

Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older ...

Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

Early abdominal CT may be warranted among patients with unknown or uncertain biochemical screening results for primary aldosteronism.

Crinecerfont is associated with sustained reductions in androstenedione and GC doses at 1 year in congenital adrenal hyperplasia.

COCPs were associated with improved obesity outcomes among patients with hyperandrogenic PCOS, but metformin added little ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.